Göktürk Dere
Research Subjects
Research Interests
Göktürk Dere has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Gundogdu
Dermatology and Venereology Outpatient Clinic Ordu State Hospital Ordu Turkey
2 shared publications Murat Ozturk
Hlth Sci Univ
1 shared publication
Latest Publications
- Open Access
- 8 June 2021
- Published by Wiley
Assessment of vitamin D levels in zona zoster
Aim: Vitamin D affects the secretion of antimicrobial peptides associated with toll-like receptor (TLR), which have antiviral effects. It has been suggested that vitamin D may affect the susceptibility of the host to varicella zoster virus (VZV) and the clinical course of zona zoster. Materials and Methods: In this study, 101 patients who were diagnosed with zona zoster at the dermatology outpatient clinic and had a vitamin D result at the time of diagnosis and a control group of 100 people were included. Results were analyzed statistically. Results: The 25-OH vitamin D levels of the patients ranged from 2.37 to 32.98 µg / L and the mean value was 14.25 ± 7.20 µg / L. In the control group, 25-OH vitamin D levels ranged between 10.3 and 44.25 µg / L, and the mean value was 24.9 ± 6.24 µg / L. 25-OH vitamin D levels in the patient group were significantly lower than the levels in the control group. (p <0.001) Conclusion: This study revealed that 25-OH vitamin D levels were significantly lower in patients with zona zoster compared to the control group. 25-OH vitamin D deficiency may increase the risk of VZV reactivation, and vitamin D supplementation in patients with vitamin D deficiency in zona zoster may help the mild course of the disease.
- 8 June 2021
- Published by Wiley
Open AccessAssessment of vitamin D levels in zona zoster
Aim: Vitamin D affects the secretion of antimicrobial peptides associated with toll-like receptor (TLR), which have antiviral effects. It has been suggested that vitamin D may affect the susceptibility of the host to varicella zoster virus (VZV) and the clinical course of zona zoster. Materials and Methods: In this study, 101 patients who were diagnosed with zona zoster at the dermatology outpatient clinic and had a vitamin D result at the time of diagnosis and a control group of 100 people were included. Results were analyzed statistically. Results: The 25-OH vitamin D levels of the patients ranged from 2.37 to 32.98 µg / L and the mean value was 14.25 ± 7.20 µg / L. In the control group, 25-OH vitamin D levels ranged between 10.3 and 44.25 µg / L, and the mean value was 24.9 ± 6.24 µg / L. 25-OH vitamin D levels in the patient group were significantly lower than the levels in the control group. (p <0.001) Conclusion: This study revealed that 25-OH vitamin D levels were significantly lower in patients with zona zoster compared to the control group. 25-OH vitamin D deficiency may increase the risk of VZV reactivation, and vitamin D supplementation in patients with vitamin D deficiency in zona zoster may help the mild course of the disease.
- Open Access
- 8 March 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (6) , 1568-1570
Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID‐19)?
Aim: To investigate whether acne treatment agent systemic isotretinoin causes susceptibility to COVID‐19 disease.Material and method: Patients admitted to a single center due to acne between March 2020 and December 2020 were included. A retrospective analysis was conducted on the medical records of acne patients receiving systemic isotretinoin or topical treatments. The patients with PCR‐confirmed SARS‐CoV‐2 infection were recorded.Results: 302 patients who used isotretinoin and 329 patients who used topical treatment were included in the study. No statistically significant difference was found between the groups in terms of age (p = 0.151). It was found that of the 302 patients who used isotretinoin, 33 had PCR test for SARS‐CoV‐2 and two of these had PCR positivity, while of the 329 patients who received topical treatment, 45 had PCR test and five of these had PCR positivity. No statistically significant difference was found between the groups in terms of having SARS‐CoV‐2 positivity with PCR (p = 0.692).Conclusion: Susceptibility to COVID‐19 disease was not observed in patients using systemic isotretinoin.
- 8 March 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (6) , 1568-1570
Open AccessIs systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID‐19)?
Aim: To investigate whether acne treatment agent systemic isotretinoin causes susceptibility to COVID‐19 disease.Material and method: Patients admitted to a single center due to acne between March 2020 and December 2020 were included. A retrospective analysis was conducted on the medical records of acne patients receiving systemic isotretinoin or topical treatments. The patients with PCR‐confirmed SARS‐CoV‐2 infection were recorded.Results: 302 patients who used isotretinoin and 329 patients who used topical treatment were included in the study. No statistically significant difference was found between the groups in terms of age (p = 0.151). It was found that of the 302 patients who used isotretinoin, 33 had PCR test for SARS‐CoV‐2 and two of these had PCR positivity, while of the 329 patients who received topical treatment, 45 had PCR test and five of these had PCR positivity. No statistically significant difference was found between the groups in terms of having SARS‐CoV‐2 positivity with PCR (p = 0.692).Conclusion: Susceptibility to COVID‐19 disease was not observed in patients using systemic isotretinoin.
- 8 March 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (12) , 4048-4051
Investigation of the relationship between alopecia areata and inflammatory blood parameters
Aim: Alopecia areata (AA) is an inflammatory condition that causes regional shedding without scarring on the hair or eyebrows, eyelashes, and beard. In studies conducted, it has been concluded that platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), and mean platelet volume (MPV) are significant indicators of systemic inflammation in various diseases. In the present study, our aim was to examine these parameters in AA patients and to investigate their relationship with the disease.Materials and Methods: A total of 135 AA patients and 135 healthy controls who did not have any systemic, inflammatory, infectious, or autoimmune diseases were included in this study. Demographic characteristics and complete blood count (CBC) results were analyzed retrospectively and recorded, and statistical analysis was performed.Results: PLR, NLR, and MPV values were not differ between AA patients and the control group.Conclusion: It can be concluded that PLR, NLR, and MPV values are not convenient parameters to show inflammatory response in AA.
- 8 March 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (12) , 4048-4051
Investigation of the relationship between alopecia areata and inflammatory blood parameters
Aim: Alopecia areata (AA) is an inflammatory condition that causes regional shedding without scarring on the hair or eyebrows, eyelashes, and beard. In studies conducted, it has been concluded that platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), and mean platelet volume (MPV) are significant indicators of systemic inflammation in various diseases. In the present study, our aim was to examine these parameters in AA patients and to investigate their relationship with the disease.Materials and Methods: A total of 135 AA patients and 135 healthy controls who did not have any systemic, inflammatory, infectious, or autoimmune diseases were included in this study. Demographic characteristics and complete blood count (CBC) results were analyzed retrospectively and recorded, and statistical analysis was performed.Results: PLR, NLR, and MPV values were not differ between AA patients and the control group.Conclusion: It can be concluded that PLR, NLR, and MPV values are not convenient parameters to show inflammatory response in AA.